Artigo Revisado por pares

Predictive factors of early death after a comprehensive geriatric assessment in elderly cancer patients.

2015; Lippincott Williams & Wilkins; Volume: 33; Issue: 15_suppl Linguagem: Inglês

10.1200/jco.2015.33.15_suppl.e20530

ISSN

1527-7755

Autores

Beatriz Jiménez-Munárriz, Rosário Madero, A.M. Jiménez Gordo, MJ Molina-Garrido, Juana Saldaña, Regina Gironés, Javier de Castro, Virginia Martínez-Marín, Patricia Cruz, Mar Sánchez, Maite Antonio Rebollo, Beatriz Castelo, Marisa Torres, Andrés Redondo, Beatriz Martínez, Ana Custodio, I. Ghanem Cañete, Elsa Bernal, Jaime Feliú,

Tópico(s)

Frailty in Older Adults

Resumo

e20530 Background: Objective data for decision making about treatment options in the elderly population with cancer are lacking. The purpose of this study is to analyze predictive factors of early death ( < 6 months) in older patients after initiation of chemotherapy treatment. Methods: 126 cancer patients ≥ 70 years were enrolled between January of 2012 and December of 2014. This is a prospective cohort study approved by the ethics committee of La Paz University Hospital in Madrid, Spain. A comprehensive geriatric assessment (CGA) was completed before the treatment was started. Geriatric data (Short portable mental status questionnaire – Pfeiffer -, BMI, short physical performance battery –SPPB-, ADL, IADL, HDAS score, Charlson, VES-13 and the MOS social scale) were collected. Cancer characteristics, social, demographic and analytical data were also reviewed. Predictive factors of early death were obtained from a CGA results and traditional oncology measures. Results: Median age was 77 years (70-92), 64% of the patents were male, with advanced disease in 53% of patients. ECOG PS of 0/1/2 was seen in 30%/ 61% and 9% respectively. VES 13 ≥ 7 in 14%. ADL and IADL showed impairment in 17% and 49% of the patients respectively. Thirty seven (29%) of the patients had an early death. In the multivariate analysis, significant predictive factors for early death were: a diagnosis of lung cancer (odds ratio [OR],17.85; 95%CI,[2.86 to 111.40]), metastatic disease (OR 6.9; 95%CI,[1.98 to 24.3]), lower hemoglobin levels (OR 0.553; 95% CI, [0.388 to 0.79]), and higher bilirubin level (OR, 6.403; 95% CI, [1.22 to 33.43]). Interestingly no instrument of geriatric assessment proved capable of predicting survival in our series. ROC analysis showed a good discriminatory capacity (AUC = 0.860). Conclusions: Lung cancer, metastatic disease, hemoglobin and bilirrubin levels were independent predictive factors for early death in elderly cancer patients treated with chemotherapy.

Referência(s)
Altmetric
PlumX